239 related articles for article (PubMed ID: 32317022)
1. Common gene expression signatures in Parkinson's disease are driven by changes in cell composition.
Nido GS; Dick F; Toker L; Petersen K; Alves G; Tysnes OB; Jonassen I; Haugarvoll K; Tzoulis C
Acta Neuropathol Commun; 2020 Apr; 8(1):55. PubMed ID: 32317022
[TBL] [Abstract][Full Text] [Related]
2. Differential transcript usage in the Parkinson's disease brain.
Dick F; Nido GS; Alves GW; Tysnes OB; Nilsen GH; Dölle C; Tzoulis C
PLoS Genet; 2020 Nov; 16(11):e1009182. PubMed ID: 33137089
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic profiles in Parkinson's disease.
Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A
Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic signatures of brain regional vulnerability to Parkinson's disease.
Keo A; Mahfouz A; Ingrassia AMT; Meneboo JP; Villenet C; Mutez E; Comptdaer T; Lelieveldt BPF; Figeac M; Chartier-Harlin MC; van de Berg WDJ; van Hilten JJ; Reinders MJT
Commun Biol; 2020 Mar; 3(1):101. PubMed ID: 32139796
[TBL] [Abstract][Full Text] [Related]
5. Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: implications of whole transcriptome profiling of Patients' skin.
Planken A; Kurvits L; Reimann E; Kadastik-Eerme L; Kingo K; Kõks S; Taba P
BMC Neurol; 2017 Jan; 17(1):6. PubMed ID: 28068941
[TBL] [Abstract][Full Text] [Related]
6. Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease.
Irmady K; Hale CR; Qadri R; Fak J; Simelane S; Carroll T; Przedborski S; Darnell RB
Nat Commun; 2023 Jul; 14(1):3956. PubMed ID: 37407548
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Profiling of Circular RNA in Different Brain Regions of Parkinson's Disease in a Mouse Model.
Jia E; Zhou Y; Liu Z; Wang L; Ouyang T; Pan M; Bai Y; Ge Q
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344560
[TBL] [Abstract][Full Text] [Related]
8. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
9. Differential Analysis of A-to-I mRNA Edited Sites in Parkinson's Disease.
Pozdyshev DV; Zharikova AA; Medvedeva MV; Muronetz VI
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052353
[TBL] [Abstract][Full Text] [Related]
10. The non-specific lethal complex regulates genes and pathways genetically linked to Parkinson's disease.
Hicks AR; Reynolds RH; O'Callaghan B; García-Ruiz S; Gil-Martínez AL; Botía J; Plun-Favreau H; Ryten M
Brain; 2023 Dec; 146(12):4974-4987. PubMed ID: 37522749
[TBL] [Abstract][Full Text] [Related]
11. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
Quadri M; Mandemakers W; Grochowska MM; Masius R; Geut H; Fabrizio E; Breedveld GJ; Kuipers D; Minneboo M; Vergouw LJM; Carreras Mascaro A; Yonova-Doing E; Simons E; Zhao T; Di Fonzo AB; Chang HC; Parchi P; Melis M; Correia Guedes L; Criscuolo C; Thomas A; Brouwer RWW; Heijsman D; Ingrassia AMT; Calandra Buonaura G; Rood JP; Capellari S; Rozemuller AJ; Sarchioto M; Fen Chien H; Vanacore N; Olgiati S; Wu-Chou YH; Yeh TH; Boon AJW; Hoogers SE; Ghazvini M; IJpma AS; van IJcken WFJ; Onofrj M; Barone P; Nicholl DJ; Puschmann A; De Mari M; Kievit AJ; Barbosa E; De Michele G; Majoor-Krakauer D; van Swieten JC; de Jong FJ; Ferreira JJ; Cossu G; Lu CS; Meco G; Cortelli P; van de Berg WDJ; Bonifati V;
Lancet Neurol; 2018 Jul; 17(7):597-608. PubMed ID: 29887161
[TBL] [Abstract][Full Text] [Related]
12. Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease.
Infante J; Prieto C; Sierra M; Sánchez-Juan P; González-Aramburu I; Sánchez-Quintana C; Berciano J; Combarros O; Sainz J
Neurobiol Aging; 2016 Feb; 38():214.e1-214.e5. PubMed ID: 26675812
[TBL] [Abstract][Full Text] [Related]
13. Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease.
Botta-Orfila T; Sànchez-Pla A; Fernández M; Carmona F; Ezquerra M; Tolosa E
Brain Res; 2012 Jul; 1466():152-7. PubMed ID: 22634372
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal Cortex Transcriptomic Deconvolution Implicates Monocyte Infiltration in Parkinson's Disease.
Batchu S
Neurodegener Dis; 2020; 20(2-3):110-112. PubMed ID: 32980850
[TBL] [Abstract][Full Text] [Related]
15. A review of genome-wide transcriptomics studies in Parkinson's disease.
Borrageiro G; Haylett W; Seedat S; Kuivaniemi H; Bardien S
Eur J Neurosci; 2018 Jan; 47(1):1-16. PubMed ID: 29068110
[TBL] [Abstract][Full Text] [Related]
16. Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.
Oerton E; Bender A
BMC Neurol; 2017 Mar; 17(1):58. PubMed ID: 28335819
[TBL] [Abstract][Full Text] [Related]
17. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson's disease.
Bryois J; Skene NG; Hansen TF; Kogelman LJA; Watson HJ; Liu Z; ; ; ; Brueggeman L; Breen G; Bulik CM; Arenas E; Hjerling-Leffler J; Sullivan PF
Nat Genet; 2020 May; 52(5):482-493. PubMed ID: 32341526
[TBL] [Abstract][Full Text] [Related]
18. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
19. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
Mandel SA; Fishman T; Youdim MB
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243
[TBL] [Abstract][Full Text] [Related]
20. Gene Co-Expression Network Analysis Implicates microRNA Processing in Parkinson's Disease Pathogenesis.
Chen JA
Neurodegener Dis; 2018; 18(4):191-199. PubMed ID: 30089309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
